NEW YORK, Sept 28 - ValiGen has signed a five-year deal to subscribe to all of Celera Genomic’s (NYSE: CRA) database products, the companies said Thursday.

Valigen, of Newton, PA, said it would access the databases through Celera’s web-based Discovery System.

Financial terms of the deal were not disclosed.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers describe a way to share data while keeping it secure, Agence France Presse reports.

In Science this week: genetic mutations typically associated with esophageal cancer are common in older, healthy individuals, and more.

India's Council of Scientific and Industrial Research has a new director-general, according to ScienceInsider.

A new study links more than a hundred genes to autism spectrum disorder, Discover's D-brief blog reports.